Turning Point Therapeutics, Inc.
TPTXDelisted Aug 17, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595893
Turning Point Therapeutics, Inc. was delisted on Aug 17, 2022; its insiders filed their last Form 4 on Aug 17, 2022; 209 institutions reported holding it in 13F filings for Q2 2022, worth $3.29B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Turning Point Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 190
- −12 vs. Q1 2021
- Shares held
- 46.0M
- +1.54M (+3.5%) vs. Q1 2021
- Total value
- $3.59B
- −$625.3M (−14.8%) vs. Q1 2021
- New holders
- 26
- 101 more added
- Sold out
- 38
- 39 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TPTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 209 | $3.29B |
| Q1 2022 | 154 | $1.23B |
| Q4 2021 | 172 | $2.15B |
| Q3 2021 | 191 | $2.98B |
| Q2 2021 | 190 | $3.59B |
| Q1 2021 | 202 | $4.21B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Turning Point Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −13,962−100.0% | Sold out |
| Aviva PLC | 0 | $0 | 0.00% | −12,658−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −12,107−100.0% | Sold out |
| Asymmetry Capital Management, L.P. | 0 | $0 | 0.00% | −11,873−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −10,425−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −9,500−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −8,947−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −8,900−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −8,482−100.0% | Sold out |
| Advisory Research Inc | 0 | $0 | 0.00% | −7,248−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −6,869−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −6,190−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −5,577−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −5,543−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −5,180−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −4,587−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −3,223−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −2,947−100.0% | Sold out |
| Athanor Capital, LP | 0 | $0 | 0.00% | −2,394−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −2,183−100.0% | Sold out |
| Illinois Municipal Retirement Fund | 0 | $0 | 0.00% | −1,898−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −1,094−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −1,201−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −678−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −591−100.0% | Sold out |
| RMR Wealth Builders | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Berman Capital Advisors, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |